Premature Ejaculation Treatment Market to Paramount a Market Growth of CAGR 8.7% during the Assessment Period| Top Key Competitors Analysis upto 2026
SEATTLE, April 08, 2021, (PHARMIWEB) — Premature Ejaculation Treatment Market- Insights
Ejaculation can be defined as discharge of semen from the body. Premature ejaculation (PE) also known as rapid ejaculation, premature climax or early ejaculation, which is a condition in which the ejaculation happens earlier than a man or his partner would like during a sexual intercourse. The main sign of PE is incapability to delay ejaculation for more than one minute after penetration. Mainly PE can be classified in two types, namely lifelong (primary) PE and acquired (secondary) PE.
Lifelong (primary) PE is a condition, which affects a male lifelong, nearly from the beginning of his first sexual encounter. Acquired (secondary) PE is a condition, in which a male who has a normal sex life starts suffering from PE. The actual cause of PE is not known, however, it can caused due to some psychological and biological factors such as early sexual experiences, sexual abuse, poor body image, depression, anxiety, abnormal hormone levels, inherited traits, inflammation and infection of the prostate or urethra, and worrying about premature ejaculation.
To learn more about this report, request a sample copy*
* The sample copy includes: Report Summary, Table of Contents, Segmentation, Competitive Landscape, Report Structure, Methodology.
Request a sample copy of this report@ https://www.coherentmarketinsights.com/insight/request-sample/1956
Frequent launches and approvals of novel premature ejaculation treatment products are expected to drive growth of the market
Key players in the market are focusing on launching new products, which in turn is expected to aid in growth of the market. For instance, in 2012, Absorption Pharmaceuticals, LLC launched its Promescent, an over-the-counter lidocaine-based spray, indicated for premature ejaculation. Furthermore, in 2013, Absorption Pharmaceuticals, LLC received patent for its Promescent, for premature ejaculation (PE) from the U.S. Patent and Trademark Office. The launches of novel drugs, which are indicated for the treatment of premature ejaculation is expected to fuel growth of the global premature ejaculation treatment market in the near future.
The global premature ejaculation treatment market was valued at US$ 1.5 Bn in 2017, and is expected to exhibit a CAGR of 8.7% over the forecast period (2018-2026).
Figure 1. Global Premature Ejaculation Treatment Market Share (%), By Region, 2022
Source: Coherent Market Insights Analysis (2018)
Access research reports that are tailored specifically for you and your organization in order to explore practical growth strategies and recommendations
Buy-Now this Research Report @ https://www.coherentmarketinsights.com/insight/buy-now/1956
Increasing strategic collaborations for development of new diagnostic tools is expected to propel the market growth
Key players in the market are involved in strategic collaborations for the development of premature ejaculation treatment drugs. For instance, in 2012, Ampio Pharmaceuticals, Inc. entered in a strategic agreement with Ethypharm S.A. for the manufacturing of Zertane, Ampio’s drug indicated for the treatment of premature ejaculation. In 2013, Absorption Pharmaceuticals LLC entered into a strategic collaboration with Kaiser Permanente for initiating clinical trial to evaluate the efficacy of Promescent lidocaine spray for men with premature ejaculation (PE). Such strategic collaborations by key players for the development, manufacturing, and evaluation of novel drugs is expected to fuel the global premature ejaculation treatment market growth.
Figure 2. North America Premature Ejaculation Treatment Market Share (%), By Country, 2022
Source: Coherent Market Insights Analysis (2018)
Furthermore, key players are involved in raising funds for the development of drugs and are focused on expanding its sales network, in order to increase their sales. For instance, in 2013, Absorption Pharmaceuticals LLC, a manufacturer of Promescent spray indicated for treatment of premature ejaculation, expanded its international sales team. In 2014, Vyrix Pharmaceuticals, Inc., a subsidiary of Aytu BioScience, raised around US$ 28.75 million. The company financed development of tramadol hydrochloride (Zertane), indicated for the treatment of premature ejaculation from these funds.
Increasing prevalence of premature ejaculation is expected to increase demand for premature ejaculation drugs. For instance, according to the data published by European Association of Urology in 2017, the prevalence rate of premature ejaculation in the U.S. was estimated to be 30% (18-29 years), 32% (30-39 years), 28% (40-49 years), and 55% (50-59 years). According to the same source, the prevalence rate of four sub-types of erectile dysfunction was were 2.3% (lifelong PE), 3.9% (acquired PE), 8.5% (natural variable PE), and 5.1% (premature-like ejaculatory dysfunction). Such high prevalence of premature ejaculation is expected to lead to high demand for its treatment drugs and drive premature ejaculation treatment market growth.
Launch of alternative treatment methods for premature ejaculation is expected to be a major factor, which is expected to hamper the market growth. For instance, in May 2018, InnovaDerma PLC launched a device, Prolong. Prolong is a FDA approved device used in the treatment of premature ejaculation. Launches of such devices is expected to restrain growth of the global premature ejaculation treatment market over the forecast period.
View Press Release For More Information @ https://www.coherentmarketinsights.com/press-release/premature-ejaculation-treatment-market-to-surpass-us-33-bn-threshold-by-2026-1016
Key players operating in the premature ejaculation treatment market include Regent Pacific Group Limited, Menarini Group, Furiex Pharmaceuticals, Inc., Absorption Pharmaceuticals, LLC, Ampio Pharmaceuticals, Inc., Aytu BioScience, NeuroHealing Pharmaceuticals Inc., and Dong-A Pharmaceutical Co., Ltd.
Table of Contents
- Research Objective and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
- Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet, By Drug Type
- Market Snippet, By Route of Administration
- Market Snippet, By Dosage Form
- Market Snippet, By Distribution Channel
- Market Snippet, By Region
- Coherent Opportunity Map (COM)
- Report Description
- Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- PEST Analysis
- Pipeline Analysis
- Product Approval
- Product Launch
- Collaboration-Acquisition
- Porter’s Five Forces Analysis
- Market Dynamics
- Global Premature Ejaculation Treatment Market, By Drug Type, 2016 – 2026 (US$ Bn)
- Introduction
- Market Share Analysis, 2018 and 2026 (%)
- Y-o-Y Growth Analysis, 2017–2026
- Segment Trends
- Selective Serotonin Reuptake Inhibitors (SSRIs)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Bn)
- Segment Trends
- Dapoxetine
- Others
- Phosphodiesterase Type 5 (PDE5) Inhibitors
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Bn)
- Segment Trends
- Zertane
- Others
- Topical Anesthetics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Bn)
- Segment Trends
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Bn)
- Introduction
- Global Premature Ejaculation Treatment Market, By Route of Administration, 2016 – 2026 (US$ Bn)
- Introduction
- Market Share Analysis, 2018 and 2026 (%)
- Y-o-Y Growth Analysis, 2017–2026
- Segment Trends
- Oral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Bn)
- Topical
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Bn)
- Introduction
- Global Premature Ejaculation Treatment Market, Dosage Form, 2016 – 2026 (US$ Bn)
- Introduction
- Market Share Analysis, 2018 and 2026 (%)
- Y-o-Y Growth Analysis, 2017 – 2026
- Segment Trends
- Pills
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Bn)
- Spray
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Bn)
- Introduction
- Global Premature Ejaculation Treatment Market, By Distribution Channel, 2016 – 2026 (US$ Bn)
- Introduction
- Market Share Analysis, 2018 and 2026 (%)
- Y-o-Y Growth Analysis, 2017–2026
- Segment Trends
- Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Bn)
- Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Bn)
- Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Bn)
- Introduction
- Global Premature Ejaculation Treatment Market, By Region, 2016 – 2026 (US$ Bn)
- Introduction
- Market Share Analysis, By Region, 2018 and 2026 (%)
- Y-o-Y Growth Analysis, For Regions, 2017–2026
- North America
- Market Size and Forecast, By Drug Type, 2016 – 2026 (US$ Bn)
- Market Size and Forecast, By Route of Administration, 2016 – 2026 (US$ Bn)
- Market Size and Forecast, By Dosage Form, 2016 – 2026 (US$ Bn)
- Market Size and Forecast, By Distribution Channel, 2016 – 2026 (US$ Bn)
- Market Size and Forecast, By Country, 2016 – 2026 (US$ Bn)
- U.S.
- Canada
- Europe
- Market Size and Forecast, By Drug Type, 2016 – 2026 (US$ Bn)
- Market Size and Forecast, By Route of Administration, 2016 – 2026 (US$ Bn)
- Market Size and Forecast, By Dosage Form, 2016 – 2026 (US$ Bn)
- Market Size and Forecast, By Distribution Channel, 2016 – 2026 (US$ Bn)
- Market Size and Forecast, By Country, 2016 – 2026 (US$ Bn)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Market Size and Forecast, By Drug Type, 2016 – 2026 (US$ Bn)
- Market Size and Forecast, By Route of Administration, 2016 – 2026 (US$ Bn)
- Market Size and Forecast, By Dosage Form, 2016 – 2026 (US$ Bn)
- Market Size and Forecast, By Distribution Channel, 2016 – 2026 (US$ Bn)
- Market Size and Forecast, By Country, 2016 – 2026 (US$ Bn)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Latin America
- Market Size and Forecast, By Drug Type, 2016 – 2026 (US$ Bn)
- Market Size and Forecast, By Route of Administration, 2016 – 2026 (US$ Bn)
- Market Size and Forecast, By Dosage Form, 2016 – 2026 (US$ Bn)
- Market Size and Forecast, By Distribution Channel, 2016 – 2026 (US$ Bn)
- Market Size and Forecast, By Country, 2016 – 2026 (US$ Bn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Africa
- Market Size and Forecast, By Drug Type, 2016 – 2026 (US$ Bn)
- Market Size and Forecast, By Route of Administration, 2016 – 2026 (US$ Bn)
- Market Size and Forecast, By Dosage Form, 2016 – 2026 (US$ Bn)
- Market Size and Forecast, By Distribution Channel, 2016 – 2026 (US$ Bn)
- Market Size and Forecast, By Country, 2016 – 2026 (US$ Bn)
- Central Africa
- South Africa
- North Africa
- Middle East
- Market Size and Forecast, By Drug Type, 2016 – 2026 (US$ Bn)
- Market Size and Forecast, By Route of Administration, 2016 – 2026 (US$ Bn)
- Market Size and Forecast, By Dosage Form, 2016 – 2026 (US$ Bn)
- Market Size and Forecast, By Distribution Channel, 2016 – 2026 (US$ Bn)
- Market Size and Forecast, By Country, 2016 – 2026 (US$ Bn)
- GCC
- Israel
- Rest of Middle East
- Introduction
- Competitive Landscape
- Heat Map Analysis
- Company Profiles
- Section
- References
- Research Methodology
- About us and Sales Contact
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies, to not-for-profit organization, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.
To know more about us, please visit our website – www.coherentmarketinsights.com
Contact:
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837
Editor Details
-
Company:
- CDN Newswire
